Eli Lilly and Co/ US5324571083 /
| 26/09/2024 22:10:00 | Chg. -15.24 | Volume | Bid02:00:00 | Ask02:00:00 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 909.32USD | -1.65% | 2.69 mill. Turnover: 1.36 bill. |
908.00Bid Size: 100 | 909.50Ask Size: 200 | 864.24 bill.USD | 0.52% | 156.24 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 5.82 USD | -16.02% |
| EPS Diluted: | 5.80 USD | -15.94% |
| Revenues per Share: | 35.91 USD | 19.58% |
| Book Value per Share: | 11.43 USD | 0.83% |
| Cash Flow per Share: | 4.46 USD | -40.14% |
| Dividend per Share: | 4.69 USD | 15.23% |
| Total | in mill. | |
| Revenues: | 34,124.10 USD | 19.56% |
| Net Income: | 5,240.40 USD | -16.08% |
| Operating Cash Flow: | 4,240.10 USD | - |
| Cash and Cash Equivalents: | 2,818.60 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 156.24 | 100.16 |
| P/S Ratio: | 25.32 | 16.23 |
| P/BV ratio: | 79.53 | 50.98 |
| P/CF Ratio: | 203.77 | 130.63 |
| PEG: | -9.75 | -6.25 |
| Earnings Yield: | 0.64% | 1.00% |
| Dividend Yield: | 0.52% | 0.80% |
| Market Capitalization | ||
| Market Capitalization: | 864.24 bill. USD | 553.87 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 950.43 mill. | |
Profitability
| Gross Profit Margin: | 79.25% |
| EBIT Margin: | 0.00% |
| Net Profit Margin: | 15.36% |
| Return on Equity: | 48.24% |
| Return on Assets: | 8.19% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.10% |
| Liquidity II / Quick Ratio: | 0.52% |
| Liquidity III / Current Ratio: | 0.94% |
| Debt / Equity Ratio: | 2.32% |
| Dynam. Debt / Equity Ratio: | 1,253.33% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
